Safety and efficacy of ertugliflozin plus sitagliptin vs either treatment alone after 52 wks in patients with type 2 diabetes poorly controlled on metformin: VERTIS FACTORIAL extension Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Pratley, R. E.; Raji, A.; Eldor, R.; Sunga, S.; Qiu, Y.; Johnson, J.; Huyck, S.; Golm, G.; Terra, S. G.; Mancuso, J. P.; Engel, S. S.; Lauring, B.

authors

Publication Date

  • September 1, 2017

webpage

published in

category

start page

  • S407

end page

  • S407

volume

  • 60